Resveratrol

hypoxia inducible factor 1 subunit alpha ; Homo sapiens







39 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34934403 Hypoxia: Role of SIRT1 and the protective effect of resveratrol in ovarian function. 2022 Jan 1
2 35415913 Resveratrol may ameliorate rheumatoid arthritis via the STAT3/HIF-1/VEGF molecular pathway. 2022 Apr 12 10
3 33112382 Sirtuin-1 inhibits endothelin-2 expression in human granulosa-lutein cells via hypoxia inducible factor 1 alpha and epigenetic modifications†. 2021 Feb 11 1
4 33521378 Hypoxia-inducible factor (HIF): The link between obesity and COVID-19. 2021 Mar 1
5 34903412 Topical administration of pterostilbene accelerates burn wound healing in diabetes through activation of the HIF1α signaling pathway. 2021 Nov 6 1
6 34917160 Identification of the Resveratrol Potential Targets in the Treatment of Osteoarthritis. 2021 4
7 31960447 A combination of pyridine-2, 4-dicarboxylic acid diethyl ester and resveratrol stabilizes hypoxia-inducible factor 1-alpha and improves hair density in female volunteers. 2020 Apr 5
8 32111491 Molecular Basis of the Beneficial Actions of Resveratrol. 2020 Feb 2
9 32238142 Resveratrol Counteracts Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog Pathway Suppression. 2020 1
10 32273826 Resveratrol protects mitochondrial quantity by activating SIRT1/PGC-1α expression during ovarian hypoxia. 2020 Apr 2
11 32482454 Significant reduction of apoptosis induced via hypoxia and oxidative stress in isolated human islet by resveratrol. 2020 Jun 25 1
12 32485183 Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer. 2020 Sep 1 4
13 32493094 Resveratrol inhibits proliferation and promotes apoptosis of keloid fibroblasts by targeting HIF-1α. 2020 Oct 4
14 32923443 Resveratrol Improves Bnip3-Related Mitophagy and Attenuates High-Fat-Induced Endothelial Dysfunction. 2020 3
15 30409902 Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection. 2019 Jan 4 2
16 30535465 Resveratrol inhibits the growth of tumor cells under chronic stress via the ADRB‑2‑HIF‑1α axis. 2019 Feb 2
17 31327131 Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. 2019 Aug 3
18 28456938 Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells. 2018 Apr 2
19 28656256 HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model. 2017 Aug 1
20 26706021 Beneficial action of resveratrol: How and why? 2016 Feb 1
21 26748400 Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line. 2016 Jun 1
22 25367760 Role of resveratrol on the cytotoxic effects and DNA damages of iododeoxyuridine and megavoltage radiation in spheroid culture of U87MG glioblastoma cell line. 2015 Jan 2
23 25384583 Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein. 2015 Mar 4
24 26074695 Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice. 2015 Jun 7 1
25 26174951 SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization. 2015 Dec 2
26 26446654 Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization. 2015 Nov 4
27 24975222 Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells. 2014 4
28 25297617 Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer. 2014 3
29 23314035 Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways. 2013 Mar 2
30 24100602 A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells. 2013 Dec 1
31 24221993 Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation. 2013 Dec 4
32 22245592 Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols. 2012 Mar 1 1
33 21914476 Resveratrol attenuates acute hypoxic injury in cardiomyocytes: correlation with inhibition of iNOS-NO signaling pathway. 2011 Oct 9 2
34 19828106 [Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia]. 2009 Oct 2
35 18674879 Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. 2008 Nov 3
36 17473185 Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. 2007 May 1 4
37 17919812 Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. 2007 Dec 8 5
38 16227395 Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. 2005 Oct 3
39 15297429 trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. 2004 Aug 1 8